Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long-Term Follow-Up Study of Subjects Treated With an Autologous T Cell Product Expressing an Antibody-Coupled T-Cell Receptor (ACTR)

NCT02840110 is registered in ClinicalTrials.gov with Cogent Biosciences, Inc. as lead sponsor.

NCT NCT02840110
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02840110 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long-Term Follow-Up Study of Subjects Treated With an Autologous T Cell Product Expressing an Antibody-Coupled T-Cell Receptor (ACTR)
Lead sponsor
Cogent Biosciences, Inc.
Phase
Observational
Overall status
Terminated
Start date
October 31, 2016
Completion date
February 23, 2021
Enrollment
22 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

b cell lymphomas, her-2 protein overexpression, multiple myeloma, solid tumor